RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCIE SCOPUS

      Ghrelin Protects Spinal Cord Motoneurons Against Chronic Glutamate Excitotoxicity by Inhibiting Microglial Activation

      한글로보기

      https://www.riss.kr/link?id=A104667584

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Glutamate excitotoxicity is emerging as a contributor to degeneration of spinal cord motoneurons in amyotrophic lateral sclerosis (ALS). Recently, we have reported that ghrelin protects motoneurons against chronic glutamate excitotoxicity through the ...

      Glutamate excitotoxicity is emerging as a contributor to degeneration of spinal cord motoneurons in amyotrophic lateral sclerosis (ALS). Recently, we have reported that ghrelin protects motoneurons against chronic glutamate excitotoxicity through the activation of extracellular signal-regulated kinase 1/2 and phosphatidylinositol-3-kinase/Akt/glycogen synthase kinase-3β pathways. Previous studies suggest that activated microglia actively participate in the pathogenesis of ALS motoneuron degeneration. However, it is still unknown whether ghrelin exerts its protective effect on motoneurons via inhibition of microglial activation. In this study, we investigate organotypic spinal cord cultures (OSCCs) exposed to threohydroxyaspartate (THA), as a model of excitotoxic motoneuron degeneration, to determine if ghrelin prevents microglial activation. Exposure of OSCCs to THA for 3 weeks produced typical motoneuron death, and treatment of ghrelin significantly attenuated THA-induced motoneuron loss, as previously reported. Ghrelin prevented THA-induced microglial activation in the spinal cord and the expression of pro-inflammatory cytokines tumor necrosis factor-α and interleukin-1β. Our data indicate that ghrelin may act as a survival factor for motoneurons by functioning as a microglia- deactivating factor and suggest that ghrelin may have therapeutic potential for the treatment of ALS and other neurodegenerative disorders where inflammatory responses play a critical role.

      더보기

      참고문헌 (Reference)

      1 Van Den Bosch L, "The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis" 1762 : 1068-1082, 2006

      2 Erşahin M, "The anti-inflammatory and neuroprotective effects of ghrelin in subarachnoid hemorrhage-induced oxidative brain damage in rats" 27 : 1143-1155, 2010

      3 Tolosa L, "TNF-α potentiates glutamate-induced spinal cord motoneuron death via NF-κB" 46 : 176-186, 2011

      4 Theil MM, "Suppression of experimental autoimmune encephalomyelitis by ghrelin" 183 : 2859-2866, 2009

      5 Rothstein JD, "Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis" 38 : 73-84, 1995

      6 Henkel JS, "Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue" 55 : 221-235, 2004

      7 Chung H, "Phosphatidylinositol-3-kinase/Akt/glycogen synthase kinase-3β and ERK1/2 pathways mediate protective effects of acylated and unacylated ghrelin against oxygen-glucose deprivation-induced apoptosis in primary rat cortical neuronal cells" 198 : 511-521, 2008

      8 Moon M, "Neuroprotective effect of ghrelin in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine mouse model of Parkinson’s disease by blocking microglial activation" 15 : 332-347, 2009

      9 Hwang S, "Neuroprotective Effect of Ghrelin Is Associated with Decreased Expression of Prostate Apoptosis Response-4" JAPAN ENDOCRINE SOC 56 (56): 609-617, 2009

      10 Philips T, "Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease" 10 : 253-263, 2011

      1 Van Den Bosch L, "The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis" 1762 : 1068-1082, 2006

      2 Erşahin M, "The anti-inflammatory and neuroprotective effects of ghrelin in subarachnoid hemorrhage-induced oxidative brain damage in rats" 27 : 1143-1155, 2010

      3 Tolosa L, "TNF-α potentiates glutamate-induced spinal cord motoneuron death via NF-κB" 46 : 176-186, 2011

      4 Theil MM, "Suppression of experimental autoimmune encephalomyelitis by ghrelin" 183 : 2859-2866, 2009

      5 Rothstein JD, "Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis" 38 : 73-84, 1995

      6 Henkel JS, "Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue" 55 : 221-235, 2004

      7 Chung H, "Phosphatidylinositol-3-kinase/Akt/glycogen synthase kinase-3β and ERK1/2 pathways mediate protective effects of acylated and unacylated ghrelin against oxygen-glucose deprivation-induced apoptosis in primary rat cortical neuronal cells" 198 : 511-521, 2008

      8 Moon M, "Neuroprotective effect of ghrelin in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine mouse model of Parkinson’s disease by blocking microglial activation" 15 : 332-347, 2009

      9 Hwang S, "Neuroprotective Effect of Ghrelin Is Associated with Decreased Expression of Prostate Apoptosis Response-4" JAPAN ENDOCRINE SOC 56 (56): 609-617, 2009

      10 Philips T, "Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease" 10 : 253-263, 2011

      11 Lladó J, "Neural stem cells protect against glutamate-induced excitotoxicity and promote survival of injured motor neurons through the secretion of neurotrophic factors" 27 : 322-331, 2004

      12 Tikka T, "Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia" 21 : 2580-2588, 2001

      13 Tikka TM, "Minocycline prevents neurotoxicity induced by cerebrospinal fluid from patients with motor neurone disease" 125 : 722-731, 2002

      14 Henkel JS, "Microglia in ALS: the good, the bad, and the resting" 4 : 389-398, 2009

      15 González-Scarano F, "Microglia as mediators of inflammatory and degenerative diseases" 22 : 219-240, 1999

      16 Yoo YS, "Inhibition of Apoptotic Cell Death by Ghrelin Improves Functional Recovery after Spinal Cord Injury" ENDOCRINE SOC 151 (151): 3815-3826, 2010

      17 Weydt P, "Increased cytotoxic potential of microglia from ALS-transgenic mice" 48 : 179-182, 2004

      18 Lasiene J, "Glial cells in amyotrophic lateral sclerosis" 2011 : 718987-, 2011

      19 Kojima M, "Ghrelin: structure and function" 85 : 495-522, 2005

      20 Peino R, "Ghrelin-induced growth hormone secretion in humans" 143 : 11-14, 2000

      21 Date Y, "Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans" 141 : 4255-4261, 2000

      22 Lim E, "Ghrelin protects spinal cord motoneurons against chronic glutamate-induced excitotoxicity via ERK1/2 and phosphatidylinositol-3-kinase/Akt/glycogen synthase kinase-3β pathways" 230 : 114-122, 2011

      23 Andrews ZB, "Ghrelin promotes and protects nigrostriatal dopamine function via a UCP2-dependent mitochondrial mechanism" 29 : 14057-14065, 2009

      24 Kojima M, "Ghrelin is a growth-hormone-releasing acylated peptide from stomach" 402 : 656-660, 1999

      25 Huang CX, "Ghrelin inhibits post-infarct myocardial remodeling and improves cardiac function through anti-inflammation effect" 30 : 2286-2291, 2009

      26 Kim E, "Ghrelin inhibits apoptosis in hypothalamic neuronal cells during oxygen-glucose deprivation" ENDOCRINE SOC 148 : 148-159, 2007

      27 Lee J, "Ghrelin attenuates kainic acid-induced neuronal cell death in the mouse hippocampus" 205 : 263-270, 2010

      28 Jiang H, "Ghrelin antagonizes MPTPinduced neurotoxicity to the dopaminergic neurons in mouse substantia nigra" 212 : 532-537, 2008

      29 Turner MR, "Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study" 15 : 601-609, 2004

      30 Rothstein JD, "Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis" 326 : 1464-1468, 1992

      31 Rothstein JD, "Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity" 90 : 6591-6595, 1993

      32 del Rio-Hortega P, "Art and artifice in the science of histology" 22 : 515-525, 1993

      33 Obay BD, "Antiepileptic effects of ghrelin on pentylenetetrazole-induced seizures in rats" 28 : 1214-1219, 2007

      34 Chow KB, "Anti-inflammatory activity of ghrelin in human carotid artery cells" 32 : 402-409, 2009

      35 Goodall EF, "Amyotrophic lateral sclerosis (motor neuron disease): proposed mechanisms and pathways to treatment" 8 : 1-22, 2006

      더보기

      동일학술지(권/호) 다른 논문

      동일학술지 더보기

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-04-29 학술지명변경 외국어명 : THE KOREAN JOURNAL OF Physiology & Pharmacology -> The Korean Journal of Physiology & Pharmacology KCI등재
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2011-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2009-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2007-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2006-10-12 학술지명변경 한글명 : 대한 생리.약리학회지 -> The Korean Journal of Physiology & Pharmacology
      외국어명 : THE KOREAN JOURNAL OF Physilogy & Pharmacology -> THE KOREAN JOURNAL OF Physiology & Pharmacology
      KCI등재
      2004-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2003-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2001-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 1.85 0.36 1.29
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      1.05 0.9 0.575 0.09
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼